4.7 Article

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone

A. Mueller et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2006)

Article Immunology

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

A Hermanowski-Vosatka et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Endocrinology & Metabolism

Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans

R Basu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Endocrinology & Metabolism

Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity

EE Kershaw et al.

DIABETES (2005)

Article Medicine, General & Internal

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

V Fonseca

AMERICAN JOURNAL OF MEDICINE (2003)

Article Medicine, Research & Experimental

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

H Masuzaki et al.

JOURNAL OF CLINICAL INVESTIGATION (2003)

Article Multidisciplinary Sciences

A transgenic model of visceral obesity and the metabolic syndrome

H Masuzaki et al.

SCIENCE (2001)

Article Endocrinology & Metabolism

Tissue-specific dysregulation of cortisol metabolism in human obesity

E Rask et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)